eyeinthesky, you totally miss my point, of course there were less shares , but there was also much less valuable IP in their stable back then,that $8 was based on one drug, they have multiple drugs now, all with huge potential, I also happen to think it is undervalued at 29.5c.
All small Biotech investments are risky, but I believe some of the risk has been diluted a great deal purely by the fact that some of the drugs they have are analogues of an earlier drug which is a lot further advanced along the trials path but is far less potent than this newer drug.
I also believe this new manufacturing method which allows them to bend and insert different particles into the drug is a winner.
NRT Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
